Dr Yael Mauer Details Underlying Mechanisms of GLP-1s, Patie

Yael Mauer, MD, MPH, discusses the patient population who benefits most from interventions with glucagon-like peptide-1 (GLP-1) therapies and explores the underlying mechanisms at work.

Related Keywords

United States , American , Yael Mauer , Institute For Value , Department Of Endocrinology , Value Based Medicine , Cleveland Clinic , American Journal ,